Fighting prostate cancer, from farm to table, at MSU
With a nod to bringing local, fresh ingredients directly to our dinner plates, Michigan State University researchers will soon be applying their own farm-to-table approach to the fight against prostate cancer. From therapeutic ingredient production to research and testing — it’s all happening at MSU.
The special ingredient in this approach is promethium-149, or 149Pm.
This isotope has promising qualities for targeted radiotherapy — a process that delivers radioactive isotopes directly to cancer cells to damage their DNA.
College of Human Medicine recruits leading cancer researchers Jeff and Jenny Klomp
On a sunny morning this past June, scientists around the world woke up to news that could fundamentally change the game in cancer research and care. And two of the people behind that breakthrough are now working at Michigan State University.
Jenny Klomp, PhD, and Jeff Klomp, PhD, were recently recruited to the College of Human Medicine as assistant professors in the Department of Medicine. They began establishing their labs at the Grand Rapids Research Center in August.
MSU researcher identifies ways to reduce cancer risk among LGBTQIA+ people
Socioeconomic status, provider-patient relationships and rural living environments have been found to affect cancer screening behaviors for LBGTQIA+ individuals, according to a recent study from Callie Kluitenberg Harris, a doctoral candidate in the Michigan State University College of Nursing.
“With a better understanding of cancer screening discrepancies among sexual minorities, the probability of finding a cancer early is greatly enhanced and ultimately reduces the risk of death from a late-stage diagnosis,” Harris said.
MSU, Corewell Health mark 17-year partnership by adding $1M investment in exploratory research
For 17 years, the Michigan State University College of Human Medicine and Corewell Health in Grand Rapids, Michigan, have funded more than $27 million in exploratory and developmental research projects that have brought together the clinical and scientific strengths of both institutions.
Now that partnership, known as the Corewell Health – MSU Alliance Corporation, is adding another $1 million to the total with a new round of grant funding that will help advance innovative treatments for patients.